The Pandemic is Not Over, Novavax (NVAX) PT Raised to $272 at Cantor Fitzgerald Jun 15, 2021 07:33AM
Pre-Open Stock Movers 01/29: (SIEB) (GME) (NVAX) Higher; (UK) (OTLK) (EVLO) Lower (more...) Jan 29, 2021 09:29AM
After-Hours Stock Movers 01/28: (KOSS) (GME) (NVAX) Higher; (EVLO) (ADMP) (JNP) Lower (more...) Jan 28, 2021 06:00PM
Novavax (NVAX) PT Raised to 'Street High' $148 at Cantor Fitzgerald Jul 7, 2020 01:29PM
Novavax (NVAX) Phase 2 Failure Represents Significant Lost Opportunity - Cantor Fitzgerald Sep 27, 2018 09:21AM


Apr 16, 2018 04:05PM Novavax Announces Closing of Public Offering
Apr 16, 2018 04:05PM Novavax Announces Closing of Public Offering
Apr 16, 2018 04:05PM Novavax Announces Closing of Public Offering
Apr 12, 2018 05:40AM Novavax (NVAX) Prices 30.3M Share Common Offering at $1.65/Sh
Apr 11, 2018 09:00PM Novavax Prices Public Offering of Common Stock
Apr 11, 2018 08:50PM Novavax Prices Public Offering of Common Stock
Apr 11, 2018 08:50PM Novavax Prices Public Offering of Common Stock
Jul 25, 2017 07:00AM Novavax (NVAX): RSV Vaccine Improved But Proof Is Required - Cantor
Feb 28, 2017 07:49AM Cantor Fitzgerald Maintains Neutral Rating and $2 PT on Novavax (NOVA) Following Mixed Q4 Results
Dec 16, 2016 07:57AM Cantor Fitzgerald Starts Novavax (NVAX) at Neutral
Sep 16, 2016 02:19PM Notable 52-Week Highs and Lows 9/16: (INTC) (AERI) (CRUS) High; (NVAX) (CXRX) (CSIQ) Low
Aug 7, 2014 09:32AM Pre-Open Stock Movers 8/7: (SAAS) (MCP) (SSYS) (CTRP) Higher; (NSPH) (THOR) (CSOD) Lower (more...)